Tarsus Pharmaceuticals (TARS) Ownership - Who owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TARS showed earnings on August 06, 2025. You can read more about the earnings report here.